Literature DB >> 7538957

CpG methylation represses the activity of the rat prolactin promoter in rat GH3 pituitary cell lines.

V M Ngô1, J N Laverrière, D Gourdji.   

Abstract

In the present report, we have investigated the role of DNA methylation on the binding and trans-acting properties of transcription factors involved in the regulation of the rat prolactin (rPRL) gene, specifically Pit-1. To this aim we took advantage of a model system composed of three GH3 rat pituitary tumor cell lines that greatly differed in the extent of rPRL gene methylation and in the level of rPRL gene expression. Northern blot analyses indicated that identical species of Pit-1 mRNA were present to similar extent in the three GH3 cell lines. Electrophoretic mobility shift assays further demonstrated that Pit-1 was present in nuclear extracts and displayed equal affinities to bind the 1P responsive element encompassing the -65 to -38 region of the rPRL promoter, whatever the GH3 cell line tested. These data suggested that differential expression of the rPRL gene among cell lines did not result from variable amounts of Pit-1. By combining in vitro methylation and transient transfection experiments with a rPRL promoter-driven CAT construct, we showed that extensive methylation at CpG sites abolished the expression of the reporter gene. Furthermore, in vivo competition assays demonstrated that CpG methylation inhibited gene expression by preventing the binding of transcription factors We propose that related mechanisms linked to DNA methylation might alter the activity of the endogenous PRL gene in the low expressing cell line.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538957     DOI: 10.1016/0303-7207(94)03462-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

Authors:  Stephen L Archer; Glenn Marsboom; Gene H Kim; Hannah J Zhang; Peter T Toth; Eric C Svensson; Jason R B Dyck; Mardi Gomberg-Maitland; Bernard Thébaud; Aliya N Husain; Nicole Cipriani; Jalees Rehman
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

2.  Regulation of Pdha-2 expression is mediated by proximal promoter sequences and CpG methylation.

Authors:  R C Iannello; J Young; S Sumarsono; M J Tymms; H H Dahl; J Gould; M Hedger; I Kola
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

3.  Site-specific methylation of the rat prolactin and growth hormone promoters correlates with gene expression.

Authors:  V Ngô; D Gourdji; J N Laverrière
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Transcriptional induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif.

Authors:  S Germain; T Konoshita; J Philippe; P Corvol; F Pinet
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

5.  Mechanisms underlying the tissue-specific and regulated activity of the Gnrhr promoter in mammals.

Authors:  Anne-Laure Schang; Bruno Quérat; Violaine Simon; Ghislaine Garrel; Christian Bleux; Raymond Counis; Joëlle Cohen-Tannoudji; Jean-Noël Laverrière
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-13       Impact factor: 5.555

Review 6.  Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension.

Authors:  Yu Wang; Lingling Yan; Ziming Zhang; Eric Prado; Linchen Fu; Xuefeng Xu; Lizhong Du
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.